Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedUpdated citation to reflect formal October 2025 issue publication; removed “Online ahead of print” status and adjusted publication date and minor author/name formatting.SummaryDifference0.1%
- Check18 days agoChange DetectedOverall, the page updates to announce a system status notice and a new software version (v3.2.0), removing the previous v3.1.0 reference.SummaryDifference0.8%
- Check25 days agoChange DetectedVersion bump to v3.1.0 with removal of a Rheumatoid arthritis topic from MedlinePlus Genetics topics.SummaryDifference0.1%
- Check39 days agoChange DetectedRegional naming updated and address reformatted to use 'Respublika'; revision upgraded from v3.0.1 to v3.0.2. Minor UI element 'Back to Top' removed.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has been updated to include a new research article on the safety profile of Upadacitinib, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.6%
- Check54 days agoChange DetectedThe webpage has undergone significant updates, including the addition of numerous facility names and locations across various countries, while also removing many previously listed locations. This indicates a major restructuring of the content related to geographic information.SummaryDifference18%
Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.